UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 987

Sortiert nach

Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report

Bone marrow transplantation (Basingstoke), 2017-06, Vol.52 (6), p.811-817

2017

Link zum Volltext

Verfügbarkeit prüfen

Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma

Leukemia, 2014-05, Vol.28 (5), p.993-1000

2014

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

Bone marrow transplantation (Basingstoke), 2016-06, Vol.51 (6), p.786-792

2016

Link zum Volltext

Verfügbarkeit prüfen

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

Leukemia, 2013-06, Vol.27 (6), p.1229-1235

2013

Link zum Volltext

Verfügbarkeit prüfen

Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years

Bone marrow transplantation (Basingstoke), 2015-02, Vol.50 (2), p.209-215

2015

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

Bone marrow transplantation (Basingstoke), 2015-04, Vol.50 (4), p.476-482

2015

Link zum Volltext

Verfügbarkeit prüfen

Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT

Bone marrow transplantation (Basingstoke), 2015-12, Vol.50 (12), p.1542-1550

2015

Link zum Volltext

Verfügbarkeit prüfen

Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis

Bone marrow transplantation (Basingstoke), 2016-09, Vol.51 (9), p.1223-1227

2016

Link zum Volltext

Verfügbarkeit prüfen

MPN and transplantation

Leukemia research, 2016-05, Vol.44, p.S11-S11

Kröger, N

2016

Link zum Volltext

Verfügbarkeit prüfen

Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2015-09, Vol.26, p.v85-v99

2015

Link zum Volltext

Verfügbarkeit prüfen

Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice

Bone marrow transplantation (Basingstoke), 2014-02, Vol.49 (2), p.168-173

2014

Link zum Volltext

Verfügbarkeit prüfen

Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

Bone marrow transplantation (Basingstoke), 2015-08, Vol.50 (8), p.1037-1056

2015

Link zum Volltext

Verfügbarkeit prüfen

Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis

Leukemia, 2014-11, Vol.28 (11), p.2235-2240

2014

Link zum Volltext

Verfügbarkeit prüfen

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

Leukemia, 2017-10, Vol.31 (10), p.2161-2171

2017

Link zum Volltext

Verfügbarkeit prüfen

Significance of Allogeneic Stem Cell Transplantation

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e19-e19

Kröger, N

2015

Link zum Volltext

Verfügbarkeit prüfen

Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 2014-07, Vol.49 (7), p.865-872

2014

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation

Bone marrow transplantation (Basingstoke), 2014-06, Vol.49 (6), p.744-750

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of molecular residual disease post allografting in myelofibrosis patients

Bone marrow transplantation (Basingstoke), 2017-11, Vol.52 (11), p.1526-1529

2017

Link zum Volltext

Verfügbarkeit prüfen

JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis

Leukemia, 2014-08, Vol.28 (8), p.1736-1738

2014

Link zum Volltext

Verfügbarkeit prüfen

Cost analysis of patients undergoing allogeneic stem cell transplantation or chimeric antigen receptor T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma from a German healthcare payer perspective

Bone marrow transplantation (Basingstoke), 2024-04, Vol.59 (4), p.572-574

2024

Link zum Volltext

Verfügbarkeit prüfen

Live Diatom Silica Immobilization of Multimeric and Redox-Active Enzymes

Applied and Environmental Microbiology, 2012-01, Vol.78 (1), p.211-218

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)

Leukemia, 2017-11, Vol.31 (11), p.2523-2525

2017

Link zum Volltext

Verfügbarkeit prüfen

Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany

Bone marrow transplantation (Basingstoke), 2017-12, Vol.52 (12), p.1651-1657

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 987

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(849)
Mit Volltextzugriff
(938)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(913)
Japanisch
(126)
Deutsch
(62)
Französisch
(14)
Russisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(648)
Life Sciences & Biomedicine
(492)
Humans
(436)
Hematology
(319)
Female
(277)
Male
(250)
Middle Aged
(246)
Adult
(228)
Oncology
(225)
Transplantation
(217)
Biological And Medical Sciences
(174)
Medical Sciences
(160)
Immunology
(159)
Aged
(147)
Medicin Och Hälsovetenskap
(136)
Stem Cells
(127)
Stem Cell Transplantation
(124)
Biophysics
(121)
Physical Sciences
(120)
Hematopoietic Stem Cell Transplantation
(110)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Bone Marrow Transplantation
(153)
Leukemia
(53)
Blood
(36)
Haematologica
(34)
Biology Of Blood And Marrow Transplantation
(29)
Applied Physics Letters
(16)
British Journal Of Haematology
(16)
Annals Of Hematology
(14)
Journal Of Clinical Oncology
(14)
Leukemia Research
(14)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report

Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma

Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT

Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

MPN and transplantation

Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice

Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

Significance of Allogeneic Stem Cell Transplantation

Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation

Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation

Impact of molecular residual disease post allografting in myelofibrosis patients

JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis

Cost analysis of patients undergoing allogeneic stem cell transplantation or chimeric antigen receptor T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma from a German healthcare payer perspective

Live Diatom Silica Immobilization of Multimeric and Redox-Active Enzymes

Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)

Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany

Suchergebnisse filtern